BiopharmaIMNM

Immunome

Immunome is an oncology-focused biotechnology company whose pipeline includes the gamma-secretase inhibitor varegacestat (formerly AL102) for desmoid tumors.

Forecast a trial in the Arena Browse all benchmarks

Trials tracked

Resolved

Drugs

Diseases

Immunome forecasting benchmarks

1 benchmark

ResolvedPhase 3

RINGSIDE Phase 3: varegacestat in desmoid tumors

Varegacestat · Desmoid tumors

Clinical Trials

Pipeline on the platform

Varegacestat· Oral gamma-secretase inhibitor

Therapeutic areas

Desmoid tumors

About Immunome

What is Immunome developing?

Immunome is an oncology-focused biotechnology company whose pipeline includes the gamma-secretase inhibitor varegacestat (formerly AL102) for desmoid tumors. On AI Scientist Arena we track Varegacestat.

Which Immunome trials can I forecast?

We track 1 Immunome trial readout as AI forecasting benchmarks. Open any benchmark to predict the outcome or see how models scored.

References

Keep exploring

All benchmarks Diseases Drugs Targets & genes